Matter Number:
P989316
Related Federal Register Notice:
Comments From Members of Congress
Summaries of Communications
-
Summary of Communications Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5) (2013) (April 3, 2013 Meeting Attended by Commissioner Wright, Three of His Attorney Advisors, Three Commission Staff Members, and Representatives of the Pharmaceutical Research and Manufacturers of America) (10.62 KB)
-
Summary of Communications Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5)(2013) (April 18, 2013 Meeting Attended by Chairwoman Ramirez, One of Her Attorney Advisors and Her Honors Paralegal, and Representatives of the Pharmaceutical Research and Manufacturrers of America) (23.38 KB)
-
Letter Dated June 7, 2013, From Stephen Weissman, Baker Botts LLP, Representing the Pharmaceutical Research and Manufacturers of America, to Commissioner Wright, Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5)(2013). (1.11 MB)
-
Summary of Communications Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5) (2013) (March 13, 2013 Meeting Attended by Commissioner Brill, Two of Her Attorney Advisors, Four Commission Staff Members, and Representatives of the Pharmaceutical Research and Manufacturers of America). (31.32 KB)
-
Summary of Communications Placed on the Public Record Pursuant to Commission Rule 1.26(b)(5), 16 C.F.R. 1.26(b)(5) (2013) (February 26, 2013 Meeting Attended by Commissioner Ohlhausen, Two of Her Attorney Advisors, and Representatives of the Pharmaceutical Research and Manufacturers of America). (21.5 KB)
Comments